After Voting Against Saving Newborn Survivors of Abortion,

New Post Public Reply Private Reply Replies (0) Message Board
Lmcat
249
After Voting Against Saving Newborn Survivors of Abortion, Dems Voted To Save Kittens

Newborn-for-April-9-592x331.jpg
The sight of a newborn is enough to melt most hearts, but some Democrats seem to care more about protecting baby kittens than baby human beings

Sometimes a story comes along that leaves you not knowing whether to laugh or cry. This is one of them.

It seems like something that was ripped from a satirical news site, like Babylon Bee or The Onion: Democrats in Washington have voted to help protect kittens from cruel treatment, just a month after voting down legislation to save live human children from even worse situations.

But it’s not a parody. It’s real life, and it just happened in our nation’s Capitol.

“Four Democratic senators who voted against protecting newborns sponsored a bill designed to protect baby cats,” the Washington Free Beacon reported on Thursday.

“Senators Jeff Merkley, Cory Booker, Gary Peters, and Tom Udall cosponsored (the KITTEN Act of 2019) designed to put an end to animal testing using kittens.”

Recognize those names? They’re all Democrats, but they have something else in common.

The KITTEN Act “was introduced about a week after all of those Democratic senators voted to block legislation that would have required doctors to provide medical care to newborns who survive abortion,” the Free Beacon noted.

In February, nearly all Democrats voted against the Born Alive Abortions Survivors Protection Act. As you may recall, that measure wasn’t about “routine” abortions but was meant to treat live-born children from failed abortions as human beings who have a right to emergency medical care.

Yes, we’re officially at a point where the left feels more compelled to protect baby cats than baby humans — something that several conservatives were quick to lament.

“There is nothing more valuable than human life, and as a society we must defend it at every stage,” noted Lauren Fine, a spokeswoman for Rep. Steve Scalise, the Louisiana Republican who almost lost his own life to a gunman in an attack in Alexandria, Virginia, in 2017.

“It’s unfathomable that Democrats can find time to defend the lives of kittens, but at the same time are vehemently opposed to even the consideration of legislation designed to protect infants born alive during an abortion from being killed,”
Fine continued, according to the Free Beacon.

Follow the money, as they say. While animal testing is certainly something that should be reduced, the spending focused on continuing research using tissue from aborted human beings at the same time is rather sobering.

Over $100 million of taxpayer money is spent every year on projects involving fetal tissue — or to put it bluntly, research using organs and parts from aborted babies. Liberals want to increase it, while the current administration has pushed to cut that spending back.

“I find it appalling that Democrats are so out of touch that they refuse to stand up for defenseless babies but are more than eager to defend animals,”
Rep. Sean Duffy, a Republican from Wisconsin, told the Free Beacon.

“When Democrats want to talk about ending ‘taxpayer-funded kitten slaughter,’ they say it’s just common sense,” a Republican aide commented to Free Beacon. “When millions of pro-life Americans want to end taxpayer subsidies to the nation’s largest abortion business, Democrats rush to call it an extremist agenda.”


If there was any doubt about how messed up our society and representatives are in 2019, this should clear it up.

Something has gone terribly, appallingly wrong in Washington — and unless America changes course, we could be headed down a very dark path.

https://www.westernjournal.com/ct/voting-savi...ve-tribune

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 0

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 206

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Air Sealing First: Boosting Home Comfort & Efficiency

Updated Category News Views 0

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 64

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 50

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 208

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 79

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 287

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 7

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 124

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading

Top 5 Most Recently Viewed Articles

Red Cat Holdings Faces Class Action Lawsuit from Investors

Updated Category News Views 209

Overview of the Class Action Against Red Cat Holdings Pomerantz LLP has announced that a class action lawsuit has been initiated against Red Cat Holdings, Inc. (RCAT) and certain officers due to allegations of misconduct. The legal action is filed in the United States District Court for the District of New Jersey. This lawsuit represents a class of individuals or entities...

Continue Reading
IPVanish: The Ultimate Solution for Cloud Storage Security

Updated Category News Views 129

IPVanish: Leading the Charge in Cloud Security As more individuals and businesses migrate to the cloud, the urgency for secure storage solutions has skyrocketed. IPVanish has stepped up to become a standout player in this landscape, recognized for its outstanding cloud access tools and strong privacy measures. Transformation into a Comprehensive Security Platform...

Continue Reading
Runway Growth Capital Bolsters Leadership with Rovner

Updated Category News Views 11

A New Era for Runway Growth Capital Alright folks, here's the scoop for anyone tracking the moves in the growth lending space: Michael Rovner, with his hefty 30-year career in the financial sector, is now taking on the role of Co-Chief Executive Officer and Co-Chief Investment Officer at Runway Growth Capital. This guy's a veteran, no doubt, having navigated the overlaps...

Continue Reading
Investors Anticipate Earnings from Booz Allen Hamilton Soon

Updated Category News Views 134

Market Expectations for Booz Allen Hamilton's Earnings Booz Allen Hamilton (NYSE: BAH) is set to unveil its quarterly earnings soon, and it's important for investors to be well-prepared. Analysts anticipate an earnings per share (EPS) of $1.51, a key figure to watch as it could impact stock sentiment significantly. Performance Insights and Analyst Predictions The hope...

Continue Reading
USD/JPY Holds Steady Amid Economic Shifts and Data Releases

Updated Category News Views 124

USD/JPY Stabilizes After Inflation Adjustments The USD/JPY currency pair has recently stabilized after a brief drop below the key level of 141.77. This dip happened just before the US Consumer Price Index (CPI) was announced, revealing an inflation rate of 2.5%. Following this data release, the currency pair started to rebound, thanks in part to a slight increase in US...

Continue Reading